Cargando…

Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer’s disease patients

BACKGROUND: Beta-amyloid (Abeta) and tau protein in cerebrospinal fluid (CSF) are established diagnostic biomarkers for Alzheimer’s disease (AD). However, these biomarkers may not the only ones existing parameters that reflect Alzheimer’s disease neuropathological change. The use of quantitative met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berezhnoy, Georgy, Laske, Christoph, Trautwein, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483152/ https://www.ncbi.nlm.nih.gov/pubmed/37693649 http://dx.doi.org/10.3389/fnagi.2023.1219718

Ejemplares similares

Quantitative NMR-Based Lipoprotein Analysis Identifies Elevated HDL-4 and Triglycerides in the Serum of Alzheimer’s Disease Patients
por: Berezhnoy, Georgy, et al.
Publicado: (2022)

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
por: Trushina, Eugenia, et al.
Publicado: (2013)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
por: Zhu, Yueli, et al.
Publicado: (2022)

Depressive symptoms and CSF Alzheimer's disease biomarkers in relation to clinical symptom onset of mild cognitive impairment
por: Chan, Carol K., et al.
Publicado: (2020)

Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis
por: Zhou, Futao, et al.
Publicado: (2023)

CSF tau and β-amyloid as biomarkers for mild cognitive impairment
por: Hampel, Harald, et al.
Publicado: (2004)

CSF neurochemical profile and cognitive changes in Parkinson’s disease with mild cognitive impairment
por: Paolini Paoletti, Federico, et al.
Publicado: (2023)

Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease
por: Ouma, Shinji, et al.
Publicado: (2018)

Higher baseline levels of CSF inflammation increase risk of incident mild cognitive impairment and Alzheimer's disease dementia
por: Contreras, Joey A., et al.
Publicado: (2022)

Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis
por: Dulewicz, Maciej, et al.
Publicado: (2022)

Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers
por: Grambaite, Ramune, et al.
Publicado: (2013)

CSF contamination contributes to apparent microstructural alterations in mild cognitive impairment
por: Berlot, Rok, et al.
Publicado: (2014)

Association Analysis of Peripheral and CSF Biomarkers in Late Mild Cognitive Impairment
por: Zhang, Tao, et al.
Publicado: (2020)

Selection of subjects for clinical trials in Alzheimer’s disease and mild cognitive impairment with machine learning analysis of MRI and CSF biomarkers
por: Escudero, Javier, et al.
Publicado: (2011)

Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease
por: Jiang, Hong, et al.
Publicado: (2011)

Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults
por: Sible, Isabel J., et al.
Publicado: (2022)

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
por: Palmqvist, Sebastian, et al.
Publicado: (2012)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer’s disease
por: Sohn, Dongwha, et al.
Publicado: (2018)

Elevated Angiopoietin-1 Serum Levels in Patients with Alzheimer's Disease
por: Schreitmüller, Brigitte, et al.
Publicado: (2012)

Writing Impairments in Japanese Patients with Mild Cognitive Impairment and with Mild Alzheimer's Disease
por: Hayashi, Atsuko, et al.
Publicado: (2015)

Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer’s disease
por: Jiang, Xiong, et al.
Publicado: (2021)

Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer’s Disease
por: Kellar, D., et al.
Publicado: (2021)

Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer’s Disease
por: Mattsson, Niklas, et al.
Publicado: (2013)

Cerebrospinal Fluid Metabolomics: Pilot Study of Using Metabolomics to Assess Diet and Metabolic Interventions in Alzheimer’s Disease and Mild Cognitive Impairment
por: Hanson, Angela J., et al.
Publicado: (2023)

The Fornix in Mild Cognitive Impairment and Alzheimer’s Disease
por: Nowrangi, Milap A., et al.
Publicado: (2015)

Judgment in Mild Cognitive Impairment and Alzheimer's disease
por: Capucho, Patrícia Helena Figueirêdo Vale, et al.
Publicado: (2011)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Differential White Matter Connectivity in Early Mild Cognitive Impairment According to CSF Biomarkers
por: Lim, Jae-Sung, et al.
Publicado: (2014)

Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification
por: Borkowski, Kamil, et al.
Publicado: (2021)

Metabolomic alterations in the blood plasma of older adults with mild cognitive impairment and Alzheimer’s disease (from the Nakayama Study)
por: Ozaki, Tomoki, et al.
Publicado: (2022)

Estimation of Tau and Phosphorylated Tau(181) in Serum of Alzheimer’s Disease and Mild Cognitive Impairment Patients
por: Shekhar, Shashank, et al.
Publicado: (2016)

The Differences of Serum Metabolites Between Patients With Early-Stage Alzheimer's Disease and Mild Cognitive Impairment
por: Weng, Wei-Chieh, et al.
Publicado: (2019)

Automatic morphometry in Alzheimer's disease and mild cognitive impairment()()
por: Heckemann, Rolf A., et al.
Publicado: (2011)

Brain imaging of mild cognitive impairment and Alzheimer's disease
por: Yin, Changhao, et al.
Publicado: (2013)

Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
por: Chalermpalanupap, Termpanit, et al.
Publicado: (2013)

Anosognosia and Anosodiaphoria in Mild Cognitive Impairment and Alzheimer's Disease
por: Lindau, Maria, et al.
Publicado: (2014)

Prospective memory in Alzheimer’s disease and Mild Cognitive Impairment
por: Spíndola, Lívia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_06rve69fct3hk0s6if1d7cp34i